Tags

Type your tag names separated by a space and hit enter

[Technological innovation in diabetes: is it suitable for everyone and at what price?].
Soins. 2012 AprS

Abstract

Tools for monitoring diabetes such as glucose testing devices, continuous glucose monitoring and telemedicine in particular, those for treating the disease such as insulin pens and pumps, or the "artificial pancreas", are constantly improving thanks to technological advances, which also concern preventative treatments. However, these new techniques are particularly costly. They also require considerable investment from the multidisciplinary nursing team in terms of therapeutic patient education.

Authors+Show Affiliations

Polyclinique de médecine interne, hôpital Saint-Louis, groupe hospitalier, Lariboisière Saint-Louis, AP-HP, Paris. j-pierre.sauvanet@orange.fr

Pub Type(s)

English Abstract
Journal Article

Language

fre

PubMed ID

22649858

Citation

Sauvanet, Jean-Pierre. "[Technological Innovation in Diabetes: Is It Suitable for Everyone and at what Price?]." Soins; La Revue De Reference Infirmiere, 2012, pp. S24-8.
Sauvanet JP. [Technological innovation in diabetes: is it suitable for everyone and at what price?]. Soins. 2012.
Sauvanet, J. P. (2012). [Technological innovation in diabetes: is it suitable for everyone and at what price?]. Soins; La Revue De Reference Infirmiere, (764 Suppl), S24-8.
Sauvanet JP. [Technological Innovation in Diabetes: Is It Suitable for Everyone and at what Price?]. Soins. 2012;(764 Suppl)S24-8. PubMed PMID: 22649858.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Technological innovation in diabetes: is it suitable for everyone and at what price?]. A1 - Sauvanet,Jean-Pierre, PY - 2012/6/2/entrez PY - 2012/6/2/pubmed PY - 2012/8/15/medline SP - S24 EP - 8 JF - Soins; la revue de reference infirmiere JO - Soins IS - 764 Suppl N2 - Tools for monitoring diabetes such as glucose testing devices, continuous glucose monitoring and telemedicine in particular, those for treating the disease such as insulin pens and pumps, or the "artificial pancreas", are constantly improving thanks to technological advances, which also concern preventative treatments. However, these new techniques are particularly costly. They also require considerable investment from the multidisciplinary nursing team in terms of therapeutic patient education. SN - 0038-0814 UR - https://www.unboundmedicine.com/medline/citation/22649858/[Technological_innovation_in_diabetes:_is_it_suitable_for_everyone_and_at_what_price]_ L2 - http://www.diseaseinfosearch.org/result/2236 DB - PRIME DP - Unbound Medicine ER -